Literature DB >> 12079309

Adoptive immunotherapy of ovarian carcinoma.

A de Gramont, D Gangji, C Louvet, M L Garcia, D Tardy, J L Romet-Lemonne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12079309     DOI： 10.1006/gyno.2002.6667

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  An autologous system for culturing head and neck squamous cell carcinomas for the assessment of cellular therapies on the chorioallantois membrane.

Authors:  S Gronau; B Thess; H Riechelmann; Y Fischer; A Schmitt; M Schmitt
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-27       Impact factor: 2.503

2.  The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

Authors:  Maximilian Burger; Nicolas Thiounn; Stefan Denzinger; Jozsef Kondas; Gerard Benoit; Manuel S Chapado; Fernando J Jimenz-Cruz; Laszlo Kisbenedek; Zoltán Szabo; Domján Zsolt; Marc O Grimm; Imre Romics; Joachim W Thüroff; Tamas Kiss; Bertrand Tombal; Manfred Wirth; Marc Munsell; Bonnie Mills; Tung Koh; Jeff Sherman
Journal:  J Transl Med       Date:  2010-06-08       Impact factor: 5.531

Review 3.  Immunomodulatory effects of interferons in malignancies.

Authors:  Joseph Bekisz; Yuki Sato; Chase Johnson; Syed R Husain; Raj K Puri; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

Review 4.  Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.

Authors:  Nikos G Gavalas; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Journal:  Clin Dev Immunol       Date:  2011-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.